News for Read Beyond News
Pfizer and made an Equity Subscription Agreement with Valneva of France, which will be updating a collaboration and license deal for a Lyme disease vaccine that had been announced in the month of April 2020. Under the terms of the agreement, the company ‘Pfizer’ is going to be investing 95 million
Read More
The Medicines and Healthcare products Regulatory Agency (MHRA) of the United Kingdom has granted the Conditional Marketing Authorization (CMA) to the inactivated covid-19 vaccine candidate ‘VLA2001’ developed by Valneva in the adults aged between 18 to 50 years. The novel corona virus vaccine of Valneva has been indicated for the initial
Read More
The MHRA of the United Kingdom has approved a new corona virus vaccine for use, and the vaccine is manufactured by Valneva by using a more traditional technology, which has been similar to how the polio and flu vaccine shots are produced. The covid-19 vaccine of Valneva contains a whole copy
Read More